A Publication for the Faculty & Staff of the University of Maryland School of Medicine

SOMGIF.gif - 15389 Bytes

  

FUNfact

Did you know that the School of Medicine has 1,092 students, 702 post-graduate training residents, 968 full-time faculty, 1,799 full-time staff, and 6,800 active alumni?


headerVol2Num4sm.jpg - 1326 Bytes is produced by the University of Maryland School of Medicine Office of Public Affairs.

Donald E. Wilson, MD, MACP, Vice President for Medical Affairs and Dean, School of Medicine

Jennifer B. Litchman, Executive Editor
Jennifer L. McGinley, Contributor
Concept Foundry, Designer

Submitting Information to SOMNews Do you have news or information you would like to see in SOMNews? If so, please e-mail your submission to Jennifer Litchman, Director, Public Affairs, at jlitchman@som.umaryland.edu or fax it to 6-8520.

    

headerVol2Num5.JPG - 6852 BytesJanuary 2001  Volume 2   Number 5

A MESSAGE FROM THE DEAN

Dean.JPG - 12254 Bytes

Never before have we faced the myriad external challenges which exist today. The threats are real and the stakes are high. No threat is greater to our clinical enterprise and to the overall success of our missions than compliance with government standards in documenting, coding and billing for the patient care we provide. We live in a world of regulations which are often complex, confusing, and perhaps even contrary to our educational mission and what we believe is quality patient care. At the same time, we must work to eliminate unnecessary clinical documentation requirements which serve only to support billing.

Healthcare fraud is the second highest priority of the U.S. Depart-ment of Justice. Penalties for failure to comply can amount to tens of millions of dollars and potentially result in exclusion from participation in Medicare, Medicaid and other federal health care programs. Univer-sity Physicians, Inc. (UPI) has established a comprehensive compliance program to educate our faculty and staff on government requirements, and to monitor practice activities. This year alone we will spend close to $1 million on this effort. Each practice group has a compliance liaison and the UPI board of directors has established a compliance committee to oversee the program.

Increases in administrative expenses and reductions in reimbursement also threaten our existence. The key to our success must also include continued monitoring of the payer market and vigilance in our administrative operations. In the last two years we have proven our vigilance, with record clinical revenues of $98 million and $105 million in FY99 and FY00 respectively. The Clinical Affairs Committee (CAC) and Financial Affairs Advisory Committee (FAAC) provide critical oversight to assure that our resources are used in a fiscally prudent manner and are focused on those activities which will best serve our overall missions.

Revenue and redesign efforts within UPI have also succeeded with improved performance tracking by our practices and third party payers, as well as significant improvements in the training of clinical staff to meet the oftentimes burdensome administrative requirements imposed by the government and managed care plans. We cannot afford to lose the revenue to which we are entitled because we have failed to meet required payer standards or because of a breakdown in our own internal processes. This revenue is critical to meeting our educational, research and clinical goals. We will continue to look at so called “dashboard indicators” such as days in accounts receivable, lag in entry of charges, and claim edits and denials, and we will also endeavor to automate and integrate activities further where this would improve patient experience and practice performance.

Compliance is also a critical matter in our research activities. There is

substantial government scrutiny being applied to assure that government research funds are spent appropriately, that government payers do not reimburse for the patient services that are already covered by research grants, and that human subjects are appropriately protected. Research is critical to the success of our institution. In the most recent data compiled by the Association of American Medical Colleges (1998-99), the SOM ranked 9th among all public medical schools in research funding, and 24th among all 125 medical schools. Our faculty received awards totaling $172.6 million in FY00, which accounted for 45% of our budget. The federal government has moved to strengthen human subject protections in the wake of highly publicized events in which human subjects were not appropriately protected. Increased expectations and requirements include investigator education and credentialing, ongoing internal auditing, data safety monitoring plans for all clinical trials, and broadening the scope of substantive review by the convened Institutional Review Board (IRB). In order to meet these new requirements and expectations while maintaining timely and efficient IRB review, I have allocated additional resources and staff to the Office of Research Subjects. We will shortly double the number of IRB committees from two to four. Education programs and credentialing are in place, quality assurance auditing has begun, and the transition process from paper to electronic submissions is continuing. Service on the IRB is critical for the research enterprise of the SOM and all clinical faculty will be expected to participate.

Today’s environment is the most challenging we have ever faced. Excellent results – whether in the academic, research or patient care arena – are not enough. We must fully document what we do to charge for services rendered and to avoid large paybacks or fines for noncompliance. We must follow the maze of administrative requirements and track payers to ensure payment. Research activities must fully protect subjects and meet all clinical, accounting, and administrative standards.

Excellence in these areas will enhance our educational mission, set a sound example for our students and residents, and improve the overall experience for our patients. We have done much to promote these goals over the last several years, but much remains to be done. With the continued diligence of all faculty we will continue to thrive in this dynamic environment.

T-Giving.jpg - 35640 Bytes
(left to right) Sean Fox, first-year medical student, Bridget Hilliard, second-year medical student, and Jen Simpson, first-year medical student, and a little helper take a break from volunteering at the 11th Annual Spirit of Thanksgiving Dinner & Clothing Drive held Thanksgiving Day at Booker T. Washington Elementary School. Over 400 turkey dinners were served to the needy of West Baltimore.


HSFII Fundraising Campaign Off To Slow Start

The New Century Medicine Campaign for Health Science Facility II (HSFII) is off to a slow start in the effort to raise $7 million in private funds for the construction of the School of Medicine’s new state-of-the-art biomedical research facility.

The medical school, with Dean Wilson as the principal investigator, has secured a $2 million construction grant from the National Institutes of Health, and $820,000 dollars has been raised from 85 private donors. But the campaign is still more than $4 million short of the goal.

Thus far, only 35 faculty and staff – out of a faculty of nearly 1,000 physicians and researchers – have contributed to the building fund for a total of $62,000. “HSFII is critically important to the School of Medicine’s continued success,” said Dean Donald E. Wilson, MD, MACP. “But that success depends on the generous support of our faculty, staff, alumni and friends.”

These contributions will be used to augment more than $50 million in state funding for HSFII, which will significantly increase laboratory space and pave the way for breakthroughs in basic science,

disease prevention, and treatment. The $2 million NIH grant will be used to establish an Emerging Pathogens Research Center to provide laboratories, research offices, conference rooms, and a secure zone for storing biohazardous material. In addition, HSFII will provide the physical resources necessary to expand the School’s prestigious programs in infectious disease surveillance, the epidemiology of infectious disease, and vaccine development. “Research grants to the School of Medicine have nearly tripled in the last decade to over $172 million annually, and HSFII will allow us to continue that phenomenal growth,” said Dean Wilson.

The largest private donation to date is a $250,000 pledge from School of Medicine alumnus David B. Posner MD, a Baltimore gastroenterologist. Posner’s gift will establish the Rose and Nathan Posner Research Suites. Additional gifts ranging from $25,000 to $50,000 have been made to name research laboratories and conference rooms, and similar naming opportunities remain. If you have any questions regarding the New Century Medicine Campaign for HSFII, or would like to know more about how you can contribute to the HSFII initiative, please call the Development Office at 6-8503.


Quick Studies

Bergina Brickhouse and Yolanda Lenzy, first-year medical students, recently received $1000 scholarships from the Fetzer Institute for the 2nd National Gathering on Relationship-Centered Care (RCC) in Scottsdale, Arizona. Only 20 scholarships were presented from over one hundred nominations. The purpose of the conference is to create a strong new vision of health care based on RCC practices that enhance the well-being of practitioners, patients, and community. The Fetzer Institute is a nonprofit, private operating foundation that supports research, education, and service programs exploring the integral relationships among body, mind, and spirit.

Patricia C. Dischinger, PhD, associate professor, Department of Epidemiology and Preventive Medicine, was named a fellow by the Association of the Advancement of Automotive Medicine (AAAM). Dr. Dischinger received the honor for her significant contributions to traffic injury control during the AAAM’s annual meeting in October in Chicago. The AAAM is an international multidisciplinary organization dedicated to the prevention of injuries resulting from motor vehicle crashes.

Sharon Henry, MD, FACS, assistant professor, Department of Surgery, was elected into membership as a fellow in the American Association for the Surgery of Trauma (AAST). Dr. Henry is the first African-American woman to be elected to membership of the AAST. The honor was presented to her during the organization’s 60th annual meeting in

whitecoat.jpg - 22325 Bytes
First-year medical students Clinton Crowder (left) and Garfield Cross (right) receive their white coats from Mimi Blitzer, PhD, professor of pediatrics, and David Mallott, MD, associate dean for medical education, at the 4th Annual White Coat Ceremony held November 11th.

San Antonio in October. Membership is granted in recognition of a physician’s clinical and academic achievements in the realm of trauma care. The AAST, the country’s oldest and most revered academic trauma society, has 650 members, 35 of whom are women.

Joseph Lakowicz, PhD, professor, Department of Biochemistry and Molecular Biology, and director of the Center for Fluorescence Spectroscopy, received a patent for “Engineered Proteins for Analyte Sensing,” a device that will detect the presence of glucose in a sample. This invention has been licensed to Spectrx, Inc. in Atlanta, Georgia, for development of a transdermal glucose monitor for diabetes.

J. Glenn Morris, Jr., MD, MPH & TM, professor and chairman, Department of Epidemiology and Preventive Medicine, received the Mary Betty Stevens Award for Excellence in Clinical Research by the Maryland Chapter of the American College of Physicians. The award was presented to Dr. Morris at the Annual Scientific Meeting in December. The Mary Betty Stevens Award was created in 1994 to honor Dr. Stevens posthumously for her work in patient care and clinical research.